ATXN2 and breast cancer: Especially, the methylation at CpG sites cg07932199 (ATXN2) was suggested with nearly 100% posterior probability of sharing causal variants (rs7310615 and rs3184504) with the susceptibility to four cancers: breast cancer, CRC, endometrial cancer and lung cancer.